GPP

Great Point Partners Portfolio holdings

AUM $154M
This Quarter Return
-4.97%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$532M
AUM Growth
+$532M
Cap. Flow
+$72.8M
Cap. Flow %
13.7%
Top 10 Hldgs %
50.02%
Holding
51
New
12
Increased
11
Reduced
10
Closed
9

Top Buys

1
URGN icon
UroGen Pharma
URGN
$36.7M
2
ALKS icon
Alkermes
ALKS
$13M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
$11.7M
4
PTCT icon
PTC Therapeutics
PTCT
$11.2M
5
REPL icon
Replimune Group
REPL
$10.9M

Top Sells

1
AMLX icon
Amylyx Pharmaceuticals
AMLX
$20.9M
2
RYTM icon
Rhythm Pharmaceuticals
RYTM
$12.7M
3
VKTX icon
Viking Therapeutics
VKTX
$9.7M
4
MLYS icon
Mineralys Therapeutics
MLYS
$9.31M
5
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
$6.65M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
INSM icon
26
Insmed
INSM
$30.3B
$9.97M 1.82%
+394,872
New +$9.97M
OKUR
27
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
$8.89M 1.62%
1,167,061
+83,744
+8% +$638K
APGE icon
28
Apogee Therapeutics
APGE
$2.27B
$8.52M 1.55%
+400,000
New +$8.52M
GOSS icon
29
Gossamer Bio
GOSS
$587M
$5.19M 0.95%
+6,230,272
New +$5.19M
IGMS
30
DELISTED
IGM Biosciences
IGMS
$5.14M 0.94%
615,317
+115,317
+23% +$963K
HRTX icon
31
Heron Therapeutics
HRTX
$204M
$4.88M 0.89%
4,737,368
– –
CERE
32
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$4.69M 0.85%
+215,000
New +$4.69M
ABOS icon
33
Acumen Pharmaceuticals
ABOS
$84.2M
$4.46M 0.81%
1,074,101
+22,834
+2% +$94.8K
GBIO icon
34
Generation Bio
GBIO
$40.3M
$3.88M 0.71%
1,022,537
– –
MRTX
35
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.76M 0.68%
+86,302
New +$3.76M
TERN icon
36
Terns Pharmaceuticals
TERN
$651M
$3.25M 0.59%
+645,899
New +$3.25M
TRML icon
37
Tourmaline Bio
TRML
$645M
$2.81M 0.51%
1,000,000
+333,967
+50% +$938K
GRCL
38
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$1.67M 0.3%
579,667
-1,688,390
-74% -$4.86M
SLDB icon
39
Solid Biosciences
SLDB
$448M
$1.14M 0.21%
450,403
-134,055
-23% -$338K
ICPT
40
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-601,322
Closed -$6.65M
AMAM
41
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
– –
0
– –
VKTX icon
42
Viking Therapeutics
VKTX
$3.02B
– –
-598,550
Closed -$9.7M
TVTX icon
43
Travere Therapeutics
TVTX
$1.75B
– –
-60,000
Closed -$922K
RYTM icon
44
Rhythm Pharmaceuticals
RYTM
$6.75B
– –
-772,000
Closed -$12.7M
MRSN icon
45
Mersana Therapeutics
MRSN
$34.8M
– –
0
– –
MLYS icon
46
Mineralys Therapeutics
MLYS
$1.94B
– –
-546,059
Closed -$9.31M
MCRB icon
47
Seres Therapeutics
MCRB
$162M
– –
-938,067
Closed -$4.49M
FDMT icon
48
4D Molecular Therapeutics
FDMT
$302M
– –
-350,000
Closed -$6.32M
DTIL icon
49
Precision BioSciences
DTIL
$59.5M
– –
-7,469,736
Closed -$3.93M
APLS icon
50
Apellis Pharmaceuticals
APLS
$3.51B
– –
0
– –
1
2
3